annual CAPEX:
$3.81B+$894.41M(+30.67%)Summary
- As of today (May 21, 2025), GSK annual capital expenditures is $3.81 billion, with the most recent change of +$894.41 million (+30.67%) on December 31, 2024.
- During the last 3 years, GSK annual CAPEX has risen by +$159.89 million (+4.38%).
- GSK annual CAPEX is now -11.22% below its all-time high of $4.29 billion, reached on December 31, 2007.
Performance
GSK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$564.09M-$843.65M(-59.93%)Summary
- As of today (May 21, 2025), GSK quarterly capital expenditures is $564.09 million, with the most recent change of -$843.65 million (-59.93%) on March 31, 2025.
- Over the past year, GSK quarterly CAPEX has dropped by -$150.01 million (-21.01%).
- GSK quarterly CAPEX is now -66.26% below its all-time high of $1.67 billion, reached on December 31, 2000.
Performance
GSK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$3.66B-$150.01M(-3.94%)Summary
- As of today (May 21, 2025), GSK TTM capital expenditures is $3.66 billion, with the most recent change of -$150.01 million (-3.94%) on March 31, 2025.
- Over the past year, GSK TTM CAPEX has increased by +$673.30 million (+22.53%).
- GSK TTM CAPEX is now -14.72% below its all-time high of $4.29 billion, reached on December 31, 2007.
Performance
GSK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GSK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.7% | -21.0% | +22.5% |
| 3 y3 years | +4.4% | -26.2% | -6.8% |
| 5 y5 years | +38.0% | +27.9% | +30.4% |
GSK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.3% | -59.9% | +16.9% | -6.8% | +45.3% |
| 5 y | 5-year | at high | +52.7% | -65.5% | +27.9% | -6.8% | +47.6% |
| alltime | all time | -11.2% | +508.5% | -66.3% | +320.6% | -14.7% | >+9999.0% |
GSK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $564.09M(-59.9%) | $3.66B(-3.9%) |
| Dec 2024 | $3.81B(+30.7%) | $1.41B(+24.0%) | $3.81B(+14.0%) |
| Sep 2024 | - | $1.14B(+105.0%) | $3.34B(+17.2%) |
| Jun 2024 | - | $553.89M(-22.4%) | $2.85B(-4.5%) |
| Mar 2024 | - | $714.10M(-24.0%) | $2.99B(+2.4%) |
| Dec 2023 | $2.92B(+4.3%) | $940.06M(+45.8%) | $2.92B(-2.7%) |
| Sep 2023 | - | $644.85M(-6.4%) | $3.00B(+5.7%) |
| Jun 2023 | - | $688.78M(+7.1%) | $2.84B(+6.1%) |
| Mar 2023 | - | $643.00M(-37.1%) | $2.67B(-4.4%) |
| Dec 2022 | $2.80B(-23.4%) | $1.02B(+111.9%) | $2.80B(+11.0%) |
| Sep 2022 | - | $482.52M(-8.3%) | $2.52B(-31.4%) |
| Jun 2022 | - | $526.35M(-31.2%) | $3.67B(-6.5%) |
| Mar 2022 | - | $764.75M(+2.5%) | $3.93B(+7.6%) |
| Dec 2021 | $3.65B(+46.3%) | $746.13M(-54.4%) | $3.65B(+1.4%) |
| Sep 2021 | - | $1.64B(+109.4%) | $3.60B(+26.7%) |
| Jun 2021 | - | $781.18M(+60.1%) | $2.84B(+11.7%) |
| Mar 2021 | - | $487.99M(-29.8%) | $2.54B(+1.9%) |
| Dec 2020 | $2.50B(-9.6%) | $694.93M(-20.7%) | $2.50B(-12.1%) |
| Sep 2020 | - | $876.27M(+81.0%) | $2.84B(+14.5%) |
| Jun 2020 | - | $484.21M(+9.8%) | $2.48B(-11.6%) |
| Mar 2020 | - | $440.91M(-57.6%) | $2.81B(+1.6%) |
| Dec 2019 | $2.76B(+15.3%) | $1.04B(+101.5%) | $2.76B(+6.0%) |
| Sep 2019 | - | $515.77M(-36.4%) | $2.61B(-0.1%) |
| Jun 2019 | - | $810.75M(+104.7%) | $2.61B(+13.5%) |
| Mar 2019 | - | $396.03M(-55.2%) | $2.30B(-4.1%) |
| Dec 2018 | $2.40B(-15.7%) | $883.95M(+70.8%) | $2.40B(+1.5%) |
| Sep 2018 | - | $517.57M(+3.3%) | $2.36B(-6.5%) |
| Jun 2018 | - | $501.15M(+1.5%) | $2.52B(-10.6%) |
| Mar 2018 | - | $493.63M(-41.8%) | $2.82B(-0.8%) |
| Dec 2017 | $2.84B(-10.8%) | $848.19M(+24.6%) | $2.84B(-8.0%) |
| Sep 2017 | - | $680.84M(-14.8%) | $3.09B(+5.7%) |
| Jun 2017 | - | $798.89M(+55.1%) | $2.93B(+3.9%) |
| Mar 2017 | - | $515.23M(-53.0%) | $2.82B(-11.6%) |
| Dec 2016 | $3.19B(+9.7%) | $1.10B(+112.8%) | $3.19B(+2.8%) |
| Sep 2016 | - | $515.48M(-25.1%) | $3.10B(-5.6%) |
| Jun 2016 | - | $688.23M(-22.3%) | $3.28B(+1.4%) |
| Mar 2016 | - | $886.11M(-12.3%) | $3.24B(+11.5%) |
| Dec 2015 | $2.91B(+0.7%) | $1.01B(+44.2%) | $2.91B(+2.4%) |
| Sep 2015 | - | $700.35M(+9.2%) | $2.84B(+0.2%) |
| Jun 2015 | - | $641.51M(+16.0%) | $2.83B(-1.1%) |
| Mar 2015 | - | $553.26M(-41.2%) | $2.86B(-0.8%) |
| Dec 2014 | $2.89B(+8.5%) | $941.27M(+35.5%) | $2.89B(+5.2%) |
| Sep 2014 | - | $694.66M(+3.2%) | $2.74B(-1.0%) |
| Jun 2014 | - | $672.92M(+16.5%) | $2.77B(+0.9%) |
| Mar 2014 | - | $577.45M(-27.7%) | $2.75B(+3.2%) |
| Dec 2013 | $2.66B(+10.5%) | $799.02M(+10.6%) | $2.66B(-1.3%) |
| Sep 2013 | - | $722.61M(+11.6%) | $2.70B(+4.7%) |
| Jun 2013 | - | $647.30M(+31.5%) | $2.58B(+3.0%) |
| Mar 2013 | - | $492.42M(-41.0%) | $2.50B(+3.8%) |
| Dec 2012 | $2.41B(+13.1%) | $834.34M(+38.5%) | $2.41B(+4.1%) |
| Sep 2012 | - | $602.29M(+5.4%) | $2.31B(+7.1%) |
| Jun 2012 | - | $571.43M(+42.7%) | $2.16B(+3.0%) |
| Mar 2012 | - | $400.54M(-45.9%) | $2.10B(-1.4%) |
| Dec 2011 | $2.13B | $739.89M(+64.5%) | $2.13B(+3.0%) |
| Sep 2011 | - | $449.88M(-11.6%) | $2.07B(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $508.79M(+18.1%) | $2.46B(+0.6%) |
| Mar 2011 | - | $430.92M(-36.5%) | $2.44B(-3.1%) |
| Dec 2010 | $2.52B(-14.1%) | $678.72M(-19.2%) | $2.52B(-8.5%) |
| Sep 2010 | - | $840.10M(+70.3%) | $2.75B(+5.3%) |
| Jun 2010 | - | $493.38M(-2.9%) | $2.61B(-9.3%) |
| Mar 2010 | - | $508.34M(-44.3%) | $2.88B(-1.7%) |
| Dec 2009 | $2.93B(-23.3%) | $913.03M(+30.4%) | $2.93B(-14.2%) |
| Sep 2009 | - | $700.24M(-8.2%) | $3.42B(-5.2%) |
| Jun 2009 | - | $762.90M(+36.8%) | $3.61B(-4.1%) |
| Mar 2009 | - | $557.64M(-60.1%) | $3.76B(-1.7%) |
| Dec 2008 | $3.83B(-10.9%) | $1.40B(+57.6%) | $3.83B(+5.7%) |
| Sep 2008 | - | $887.39M(-3.2%) | $3.62B(-0.3%) |
| Jun 2008 | - | $917.08M(+47.2%) | $3.63B(+2.8%) |
| Mar 2008 | - | $622.91M(-47.8%) | $3.53B(-17.7%) |
| Dec 2007 | $4.29B(+46.5%) | $1.19B(+33.2%) | $4.29B(+5.8%) |
| Sep 2007 | - | $896.61M(+9.6%) | $4.06B(+1.0%) |
| Jun 2007 | - | $818.35M(-40.9%) | $4.02B(+2.8%) |
| Mar 2007 | - | $1.38B(+44.3%) | $3.91B(+33.4%) |
| Dec 2006 | $2.93B(+36.4%) | $959.27M(+12.0%) | $2.93B(+4.7%) |
| Sep 2006 | - | $856.56M(+20.6%) | $2.80B(+17.0%) |
| Jun 2006 | - | $710.06M(+75.6%) | $2.39B(+8.2%) |
| Mar 2006 | - | $404.42M(-51.1%) | $2.21B(+2.9%) |
| Dec 2005 | $2.15B(+12.4%) | $827.88M(+84.2%) | $2.15B(-7.1%) |
| Sep 2005 | - | $449.49M(-15.0%) | $2.31B(+10.6%) |
| Jun 2005 | - | $528.97M(+54.6%) | $2.09B(+5.1%) |
| Mar 2005 | - | $342.26M(-65.5%) | $1.99B(+4.1%) |
| Dec 2004 | $1.91B(+34.6%) | $992.14M(+337.0%) | $1.91B(+47.9%) |
| Sep 2004 | - | $227.04M(-46.9%) | $1.29B(-12.2%) |
| Jun 2004 | - | $427.43M(+61.6%) | $1.47B(+2.3%) |
| Mar 2004 | - | $264.54M(-29.1%) | $1.44B(+1.4%) |
| Dec 2003 | $1.42B(-23.0%) | $373.06M(-8.2%) | $1.42B(-16.9%) |
| Sep 2003 | - | $406.57M(+3.0%) | $1.71B(-2.5%) |
| Jun 2003 | - | $394.82M(+61.1%) | $1.75B(-2.1%) |
| Mar 2003 | - | $245.05M(-63.0%) | $1.79B(-2.8%) |
| Dec 2002 | $1.84B(+14.4%) | $661.89M(+46.8%) | $1.84B(+8.4%) |
| Sep 2002 | - | $450.87M(+4.1%) | $1.70B(+1.8%) |
| Jun 2002 | - | $433.06M(+46.0%) | $1.67B(+8.5%) |
| Mar 2002 | - | $296.68M(-42.9%) | $1.54B(-4.3%) |
| Dec 2001 | $1.61B(-3.7%) | $519.81M(+23.5%) | $1.61B(-41.7%) |
| Sep 2001 | - | $420.80M(+39.0%) | $2.76B(+32.4%) |
| Jun 2001 | - | $302.81M(-17.4%) | $2.09B(+26.9%) |
| Mar 2001 | - | $366.47M(-78.1%) | $1.64B(-1.7%) |
| Dec 2000 | $1.67B(+73.1%) | $1.67B(-753.6%) | $1.67B(>+9900.0%) |
| Sep 2000 | - | -$255.77M(+83.7%) | $0.00(-100.0%) |
| Jun 2000 | - | -$139.20M(-135.2%) | $255.77M(-35.2%) |
| Mar 2000 | - | $394.97M | $394.97M |
| Dec 1999 | $966.02M(+22.7%) | - | - |
| Dec 1998 | $787.27M(+15.8%) | - | - |
| Dec 1997 | $679.87M(+8.5%) | - | - |
| Dec 1996 | $626.32M(-42.0%) | - | - |
| Dec 1995 | $1.08B(+40.9%) | - | - |
| Jun 1995 | $766.34M(-11.0%) | - | - |
| Jun 1994 | $860.59M(-12.9%) | - | - |
| Jun 1993 | $988.27M(-5.4%) | - | - |
| Jun 1992 | $1.04B(-7.1%) | - | - |
| Jun 1991 | $1.12B | - | - |
FAQ
- What is GSK annual capital expenditures?
- What is the all time high annual CAPEX for GSK?
- What is GSK annual CAPEX year-on-year change?
- What is GSK quarterly capital expenditures?
- What is the all time high quarterly CAPEX for GSK?
- What is GSK quarterly CAPEX year-on-year change?
- What is GSK TTM capital expenditures?
- What is the all time high TTM CAPEX for GSK?
- What is GSK TTM CAPEX year-on-year change?
What is GSK annual capital expenditures?
The current annual CAPEX of GSK is $3.81B
What is the all time high annual CAPEX for GSK?
GSK all-time high annual capital expenditures is $4.29B
What is GSK annual CAPEX year-on-year change?
Over the past year, GSK annual capital expenditures has changed by +$894.41M (+30.67%)
What is GSK quarterly capital expenditures?
The current quarterly CAPEX of GSK is $564.09M
What is the all time high quarterly CAPEX for GSK?
GSK all-time high quarterly capital expenditures is $1.67B
What is GSK quarterly CAPEX year-on-year change?
Over the past year, GSK quarterly capital expenditures has changed by -$150.01M (-21.01%)
What is GSK TTM capital expenditures?
The current TTM CAPEX of GSK is $3.66B
What is the all time high TTM CAPEX for GSK?
GSK all-time high TTM capital expenditures is $4.29B
What is GSK TTM CAPEX year-on-year change?
Over the past year, GSK TTM capital expenditures has changed by +$673.30M (+22.53%)